logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10434063 B1

PDFFull Text
Date of Patent:
Oct. 08, 2019

Filed:

Mar. 21, 2018

Implant compositions for the unidirectional delivery of therapeutic compounds to the brain

Applicant:

Board of Regents, the University of Texas System, Austin, TX (US);

Inventors:

Michael J. McGinity, San Antonio, TX (US);

Feng Zhang, Pflugerville, TX (US);

John R. Floyd, San Antonio, TX (US);

James W. McGinity, Austin, TX (US);

Assignee:

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, Austin, TX (US);

Attorney:

Parker Highlander PLLC

Primary Examiner:

Kyle A Purdy

Int. Cl.
CPC ...
A61K 47/36 (2006.01); A61K 47/14 (2017.01); A61K 31/337 (2006.01); A61K 31/538 (2006.01); A61K 31/573 (2006.01); A61K 33/24 (2019.01); A61K 9/00 (2006.01); A61K 31/282 (2006.01); A61K 31/495 (2006.01); A61K 39/395 (2006.01); A61K 31/436 (2006.01); A61K 31/4745 (2006.01); A61K 31/40 (2006.01); A61K 31/704 (2006.01); A61K 31/519 (2006.01); A61K 31/155 (2006.01); A61K 31/198 (2006.01); A61K 31/661 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61L 27/54 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0085 (2013.01); A61K 9/0024 (2013.01); A61K 31/155 (2013.01); A61K 31/198 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/40 (2013.01); A61K 31/436 (2013.01); A61K 31/4745 (2013.01); A61K 31/495 (2013.01); A61K 31/519 (2013.01); A61K 31/538 (2013.01); A61K 31/573 (2013.01); A61K 31/661 (2013.01); A61K 31/704 (2013.01); A61K 33/24 (2013.01); A61K 39/3955 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/36 (2013.01); A61L 27/54 (2013.01); A61L 2430/32 (2013.01);
Abstract

The present invention provides, in some aspects, bilayered and trilayered pharmaceutical implant compositions for the unidirectional delivery of anti-cancer compounds to the brain over a period of time (e.g., several weeks, 1, 2, 3, 4, 5, 6, 7 days, or 1, 2, 3, weeks, or any range derivable therein) following the removal of glioblastoma multiforme or other malignant tumors in the brain.

Find Patent Forward Citations

McGinity, Michael. (2019). Implant compositions for the unidirectional delivery of therapeutic compounds to the brain (U.S. Patent No. 10434063). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10434063

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…